Home > Boards > Other Markets > Foreign Stock Markets > Novo Nordisk A/S (NVO)

Novo is studying the injected drug - already

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TREND1 Member Profile
Member Level 
Followed By 407
Posts 54,608
Boards Moderated 15
Alias Born 12/16/01
160x600 placeholder
TREND1 Member Level  Thursday, 10/23/14 03:31:29 PM
Re: None
Post # of 49 
Novo is studying the injected drug - already on the market as a treatment for type-2 diabetes under the brand name Victoza

- as a therapy for the seriously obese, with pivotal clinical trial results due in the first half of next year 2013.

Do not know how this turned out.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist